Nanobeak

New York, United States Founded: 2009 • Age: 17 yrs
Mobile app based health screening solution

About Nanobeak

Nanobeak is a Healthcare company based in New York (United States) founded in 2009. It operates as a mobile app based health screening solution. Its chief executive is Jeremy Barbera. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include Atrys, C the Signs, Inspirata, EDP Biotech Corporation and inveox and 5 more; 8 of its 10 listed competitors have raised funding.

Company details

Nanobeak was founded in 2009 in New York, United States, and operates in the health technology sector. A mobile application paired with a smartphone-attached device is developed to analyze volatile organic compounds in breath. Lung cancer presence is identified from a single exhalation through this sensor-based system. The device is also utilized by law enforcement for marijuana detection on breath.

People of Nanobeak

1 people are tracked at Nanobeak (1 in leadership).

NameRoleGroup
Jeremy Barbera
Chairman & CEOLeadership
Premium access

Complete people profiles for Nanobeak

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Competitors of Nanobeak

Nanobeak has 10 listed competitors in our database, 8 of them funded. They include Atrys, C the Signs, Inspirata, EDP Biotech Corporation and inveox, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
atryshealth.com2007Barcelona, Spain––
Provider of diagnostic and therapeutic services catering to cancer
cthesigns.com2016London, United Kingdom$14.92M17
Platform offering cancer prediction system for early cancer detection
inspirata.com2014Tampa, United States–42
Digital pathology solutions for cancer diagnostics are developed by Inspirata.
edpbiotech.com2005Knoxville, United States$7.59M–
Offers online purchase of diagnostic test kits and lab appointment scheduling services.
inveox.com2017Munich, Germany$25.81M–
Automated solutions for biopsy sample preparation in laboratories are provided.
nanovery.co.uk2018London, United Kingdom$2.12M1
Nanobots are developed for cancer diagnosis through bloodstream administration.
fgbiomed.com2016Haidian, China$27.71M–
Digital molecular testing tools for disease diagnosis
pathware.com2003Seattle, United States$8.46M–
Developer of cloud-based imaging and sample management platform
thynkhealth.com2014Lexington, United States$2.49M–
A lung cancer screening platform is provided using AI-based software.
insightmedbotics.com2017Hamilton, Canada$435,000–
Robotic device for breast cancer diagnosis and decision-making is developed.
Premium access

Detailed competitors of Nanobeak

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

10 companies that operate in the same segment as Nanobeak (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 716.99 M–1,832
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M–1,746
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 473.73 M–3,902
App-based health insurance is offered to individuals and businesses.
2016Paris, Ile de France, FranceUSD 863.12 M–1,606
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M992
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M–2,470
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Nanobeak

Nanobeak was founded in 2009.

Nanobeak is headquartered in New York, United States. It is registered at New York, New York, United States.

Jeremy Barbera is the current CEO of Nanobeak.

Nanobeak was founded in 2009 in New York, United States, and operates in the health technology sector. A mobile application paired with a smartphone-attached device is developed to analyze volatile organic compounds in breath. Lung cancer presence is identified from a single exhalation through this sensor-based system. The device is also utilized by law enforcement for marijuana detection on breath.

Nanobeak's top competitors include Atrys, inveox and C the Signs.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available